Navigation Links
New defibrillator signals doctor of patient's irregular heartbeat or device malfunction

Loyola first in U.S. to implant new FDA-approved device

In a major advance for heart patients, Loyola University Health System is the first hospital in the U.S. to implant into a patient a new FDA-approved defibrillator which automatically signals the doctor via wireless satellite transmission if the patient's heart beats abnormally or if the device malfunctions, e.g., battery failure.

When a patient's status changes, a built-in microchip of Biotronik's Lumos DR-T implantable cardioverter defibrillator (ICD) sends a signal to a satellite via a small transmitter that can be placed on a nightstand, worn on a belt or kept in a purse. In addition, Biotronik's Home Monitoring system virtually instantaneously sends a beat-by-beat record (similar to an electrocardiogram (ECG)) of any heart rhythm abnormality which the doctor can view on a secure website.

"The patient doesn't have to press any button or call the doctor to activate the system," said cardiac electrophysiologist Dr. Niraj Varma, associate professor of medicine, division of cardiology, Loyola University Chicago Stritch School of Medicine, and director of the cardiac electrophysiology lab, Loyola University Health System, Maywood, Ill. The notification signal is automatically generated, even if the patient is unaware of any problems. The doctor can program the device to send an alert for specific reasons, such as a significant increase in the number of irregular heartbeat (arrhythmia) episodes, as well as the preferred alert method, i.e., via email, cell phone, fax or page.

"With this surveillance system, physicians for the first time have a way to monitor non-hospitalized heart patients 24-hours-a-day, seven days a week," he said. "It will enable us to identify problems early on as well as help prevent problems."

Implanted in the chest, the ICD is a small electronic device which shocks the heart back into a healthy rhythm if it detects an abnormal heartbeat. Irregular heartbeat (arrhythmia) is a major cause of death following heart attacks. Studies have shown mortality is lower in ICD-treated patients.

"The new ICD provides faster delivery of care to patients and also reduces the number of times a patient has to go to the doctor's office for follow-up visits," said Varma, who specializes in treatment of arrhythmias.

Because patients' heart muscle pumping action can be poor as a result of the heart attack, it is important to monitor heart activity. Now it can be done 24-hours-a-day, seven-days-a-week. Varma implanted the device into a Loyola patient on Friday, August 26, 2005.

Loyola University Health System's heart program is ranked as the top program in Illinois, according to U.S. News & World Report's annual survey of more than 6,000 hospitals nationwide. This is the third year in a row that Loyola has achieved the top spot for Heart Care and Heart Surgery in the state.

Loyola opened its new 10,000-square-foot Center for Heart and Vascular Medicine on the Loyola University Medical Center campus. Loyola's 3,500-square-foot Sally & Jim Dowdle Electrophysiology Laboratories includes two dedicated fluoroscopy suites equipped with state-of-the-art multichannel digital recording systems, 3-D mapping systems, intracardiac echocardiography and a laser system.


'"/>

Source:Loyola University Health System


Related biology news :

1. Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure
2. Plants respond similarly to signals from friends, enemies
3. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
4. Scientists discover that three overlapping signals in embryo help get the backbone right
5. After a time-shift, mixed signals from the circadian clock
6. Researchers make surprise discovery that some neurons can transmit three signals at once
7. Structure-building cell signals also may influence learning and memory
8. Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage
9. Overbearing colored light may reveal a second mechanism by which birds interpret magnetic signals
10. Mayo Clinic collaboration discovers protein amplifies DNA injury signals
11. Research details how a virus hijacks cell signals to cause infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology: